- Home
- ARTW vs NERV Comparison
ARTW vs NERV Comparison
Compare ARTW & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- NERV
- Stock Information
- Founded
- ARTW 1956
- NERV 2007
- Country
- ARTW United States
- NERV United States
- Employees
- ARTW N/A
- NERV N/A
- Industry
- ARTW Industrial Machinery/Components
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- NERV Health Care
- Exchange
- ARTW Nasdaq
- NERV Nasdaq
- Market Cap
- ARTW 12.5M
- NERV 14.6M
- IPO Year
- ARTW N/A
- NERV 2014
- Fundamental
- Price
- ARTW $2.16
- NERV $4.23
- Analyst Decision
- ARTW
- NERV Hold
- Analyst Count
- ARTW 0
- NERV 1
- Target Price
- ARTW N/A
- NERV $4.00
- AVG Volume (30 Days)
- ARTW 60.3K
- NERV 417.1K
- Earning Date
- ARTW 10-07-2025
- NERV 11-05-2025
- Dividend Yield
- ARTW N/A
- NERV N/A
- EPS Growth
- ARTW N/A
- NERV N/A
- EPS
- ARTW 0.49
- NERV N/A
- Revenue
- ARTW $24,079,949.00
- NERV N/A
- Revenue This Year
- ARTW N/A
- NERV N/A
- Revenue Next Year
- ARTW N/A
- NERV N/A
- P/E Ratio
- ARTW $5.56
- NERV N/A
- Revenue Growth
- ARTW N/A
- NERV N/A
- 52 Week Low
- ARTW $1.43
- NERV $1.15
- 52 Week High
- ARTW $4.71
- NERV $12.46
- Technical
- Relative Strength Index (RSI)
- ARTW 37.57
- NERV 56.99
- Support Level
- ARTW $2.23
- NERV $3.75
- Resistance Level
- ARTW $2.47
- NERV $4.60
- Average True Range (ATR)
- ARTW 0.14
- NERV 0.37
- MACD
- ARTW -0.01
- NERV -0.04
- Stochastic Oscillator
- ARTW 9.80
- NERV 64.55
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.